TRE I Spa (Industria Italiana Integratori), a leading player in the animal health and
nutrition industry, was founded in 1968 by dott. Luigi Fezzi and now belong to
BS, one of Italy’s leading private equity firms since 2004.
The company’s administrative headquarters, its 16.000 sqm of production facilities
and warehouses, more than 10.000 of which indoors, are at Rio Saliceto in the
province of Reggio nell’Emilia.
TRE I’s constant attention to the innovative ideas which have been the cornerstone
of the company’s philosophy since its foundation means that it is now a leading
player in the veterinary industries in Italy and the other countries where it
also operates.
The company has always used cutting-edge production technologies in strict compliance
with rigid GPP (Good Production Practice) requirements and its facilities and
staff know-how are also constantly up-dated, so it can continually guarantee the
safety and high quality of its products to its clients.
Innovation – one of the key aspects of TRE I’s operational philosophy – has lead to the registration of technologies, brands
and products which are remarkable for the special attention paid to safeguarding
animal health and the respect dedicated both to the environment and their users.
TRE I has also developed and patented technologies for dust reduction in formulations
of veterinary medicines, during the production of medicated premixes, in particular.
Contamination is consequently reduced and cleaning plants is easier which results
in enhanced working and health conditions for the feedstuff factory staff.
Formulations with high stability in water solutions have also been registered
in the field of water-soluble powders.
In 1997, TRE I’s constant attention to research and development lead to the registration of
MICROAMOXTM - the first innovatory product to be introduced by TRE I to the veterinary products market.
The key feature of this innovation lies in the preparation of a premix for medical
food using amoxicillin as the active ingredient in a microencapsulated lipogelled
matrix which also protects it.
This particular formulation has bestowed unique physical and chemical features
on the active ingredient.
The dust reduction and the consequent “cross contamination” decrease in production
plants is just one of the technical advantages obtainable through this particular
formulation process, which has been designed and perfected in order to enhance
the stability of the active ingredient when it is incorporated in pellettized
feedstuffs.
This reduces the risk that thermal stress and the stress due to the pressure
exerted on the feedstuffs during pellettization while using these technologies
causes a reduction in the quality and activity of the medicine they contain.
The results attained with this technology were of such significance to suggest
its use in other important TRE I medicated products for pigs. Besides ensuring stability and low dust emissions,
these products also pass through the gastric tract without any significant degeneration
and are therefore fully able to exert their antibacterial action in the target
tissues once taken with the food thanks to the special formulation process.
Significant investments have enabled the creation of structures and instruments
leading to the optimal handling of raw materials for the production of the various
medicines and of the vitamin and mineral additive premixes.
